Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Tarsus Pharmaceuticals (TARS) over the last 5 years, with Q3 2025 value amounting to 0.71.

  • Tarsus Pharmaceuticals' Asset Utilization Ratio rose 10661.07% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 10661.07%. This contributed to the annual value of 0.57 for FY2024, which is 70522.35% up from last year.
  • According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' Asset Utilization Ratio is 0.71, which was up 10661.07% from 0.59 recorded in Q2 2025.
  • Over the past 5 years, Tarsus Pharmaceuticals' Asset Utilization Ratio peaked at 0.71 during Q3 2025, and registered a low of 0.06 during Q2 2023.
  • Its 5-year average for Asset Utilization Ratio is 0.25, with a median of 0.18 in 2021.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 7706.2% in 2022, then soared by 64311.03% in 2024.
  • Over the past 5 years, Tarsus Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.31 in 2021, then plummeted by 63.99% to 0.11 in 2022, then crashed by 41.22% to 0.07 in 2023, then soared by 643.11% to 0.49 in 2024, then surged by 46.41% to 0.71 in 2025.
  • Its last three reported values are 0.71 in Q3 2025, 0.59 for Q2 2025, and 0.53 during Q1 2025.